Patient Says AbbVie's New Trial Needs To Be On All Claims
Law360 (February 20, 2018, 10:01 PM EST) -- A patient has urged an Illinois federal court to order a new trial on all of his claims rather than maintain its decision to hold a new trial on just one claim in the first bellwether case to reach a verdict in multidistrict litigation over testosterone replacement therapies including AbbVie Inc.'s AndroGel, noting the court determined the jury verdict awarding him $150 million in punitive damages was inconsistent.
Jesse Mitchell said Friday that the court should hold a new trial on all three claims of strict liability, negligence and fraudulent misrepresentation he brought in 2014 against AbbVie for its alleged misrepresentation...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!